In this study, the PD-L1 level was upregulated by threefold in breast CSCs compared with more differentiated cancer cells, and the expression was associated with EpCAM+/CD44high/CD24low alongside EpCAM+/CD90+CSCs [76]. This evidence concerns the gene EPCAM and cancer.